Source: Boosh Plant-Based Brands.
  • Boosh Plant-Based Brands (VEGI) has closed the first tranche of  its previously announced non-brokered private placement for gross proceeds of $1,007,400
  • The company issued 1,439,143 units at a price of $0.70 per unit
  • The company reserves the right to upsize the placement for potential gross proceeds of $2,500,000
  • Boosh is a plant-based food company that sells plant-based frozen meals
  • Shares in Boosh Plant-Based Brands (VEGI) opened trading at C$0.70

Boosh Plant-Based Brands (VEGI) has closed the first tranche of  its non-brokered private placement for gross proceeds of $1,007,400.

The company issued 1,439,143 units at a price of $0.70 per unit. Each unit includes one common share and one share purchase warrant. Each warrant will entitle the holder to acquire an additional common share at a price of $1.00 until March 9, 2025.

Finder’s fees of $40,432.00 in cash and 57,760 warrants were paid in association with the closing of the initial tranche.

The proceeds of the financing will be utilized for general working capital, as well as ongoing product development and future plant based acquisition opportunities.

The company reserves the right to upsize the placement to 3,571,428 units for potential gross proceeds of $2,500,000.

All securities issued are subject to a four month hold period expiring on July 10, 2022.

Boosh is a plant-based food company that sells plant-based frozen meals to grocery outlets and independent grocery stores throughout Canada.

Shares in Boosh Plant-Based Brands (VEGI) opened trading at C$0.70.

More From The Market Online

“Paw Patrol” owners see a 52-week share price high

Spin Master (TSX:TOY) reported 8.9 per cent revenue growth to US$436.4 million and returned to profitability.

Uber Eats expands grocery delivery network with new U.S. regional retail partners

Uber (NYSE:UBER) Eats added Busch’s Fresh Food Market, Hays, and Lowe’s Market to its grocery delivery marketplace across the U.S.

Cybersecurity stocks worth watching as digital risks continue to evolve

Cybersecurity threats continue to evolve, while recent disruptions highlighted the importance of resilient digital infrastructure.

A small-cap contender looking to challenge the weight-loss drug giants

Structure Therapeutics (NASDAQ:GPCR) is developing an oral weight-loss pill that could offer an alternative to popular injectable treatments.